Gene Review:
CFI - complement factor I
Homo sapiens
Synonyms:
AHUS3, ARMD13, C3B/C4B inactivator, C3BINA, C3b-INA, ...
- Expression and regulation of complement factors H and I in rat and human cells: some critical notes. Schlaf, G., Demberg, T., Beisel, N., Schieferdecker, H.L., Götze, O. Mol. Immunol. (2001)
- A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Nilsson, S.C., Karpman, D., Vaziri-Sani, F., Kristoffersson, A.C., Salomon, R., Provot, F., Fremeaux-Bacchi, V., Trouw, L.A., Blom, A.M. Mol. Immunol. (2007)
- Suppression of immune complex-induced inflammation by the chemotactic factor inactivator. Johnson, K.J., Anderson, T.P., Ward, P.A. J. Clin. Invest. (1977)
- A chemotactic inhibitor produced by blast cells and present in the serum of a patient with acute lymphoblastic leukemia. Blumenfeld, W., Territo, M. Blood (1979)
- Lithium prophylaxis and expressed emotion. Priebe, S., Wildgrube, C., Müller-Oerlinghausen, B. The British journal of psychiatry : the journal of mental science. (1989)
- The organization of a counselling service for the families of patients undergoing bone marrow transplant. Invernizzi, G., Broich, G., Bressi, C., Guggeri, G., Caparrelli, S., Deliliers, G.L. Anticancer Res. (1999)
- Countertransference management and therapy outcome: an initial evaluation. Gelso, C.J., Latts, M.G., Gomez, M.J., Fassinger, R.E. Journal of clinical psychology. (2002)
- Correlates of hypnotizability in children: absorption, vividness of imagery, fantasy play, and social desirability. Plotnick, A.B., Payne, P.A., O'Grady, D.J. The American journal of clinical hypnosis. (1991)
- A retrospective analysis of expressed emotion (EE) and affective distress in a sample of relatives caring for traumatically brain-injured (TBI) family members. Flanagan, D.A. The British journal of clinical psychology / the British Psychological Society. (1998)
- Solubilization of immune precipitates by six isolated alternative pathway proteins. Fujita, T., Takata, Y., Tamura, N. J. Exp. Med. (1981)
- Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. Whaley, K. J. Exp. Med. (1980)
- Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b. Kazatchkine, M.D., Fearon, D.T., Silbert, J.E., Austen, K.F. J. Exp. Med. (1979)
- Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. Fujita, T., Gigli, I., Nussenzweig, V. J. Exp. Med. (1978)
- Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. Pohl, T., Seiler, C., Billinger, M., Herren, E., Wustmann, K., Mehta, H., Windecker, S., Eberli, F.R., Meier, B. J. Am. Coll. Cardiol. (2001)
- Controversies in antibiotic choices for bite wounds. Callaham, M. Annals of emergency medicine. (1988)
- Humoral inhibition of neutrophil chemotaxis in Crohn's disease. D'Amelio, R., Pallone, F., Le Moli, S., Pontesilli, O., Ricci, R., Montano, S., Rossi, P. Scand. J. Immunol. (1985)
- Dental caries experience in the Chiangmai/Lamphun provinces of Thailand. Songpaisan, Y., Davies, G.N. Community dentistry and oral epidemiology. (1989)
- Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein. Goudsmit, J., Smit, L., Klaver, B., Asher, D.M., Wolff, A., Gibbs, C.J., Gajdusek, D.C. Viral Immunol. (1987)
- Insulin-Like Growth Factor-I Induces {alpha}1B-Adrenergic Receptor Phosphorylation through G{beta}{gamma} and Epidermal Growth Factor Receptor Transactivation. Molina-Mu??oz, T., Romero-Avila, M.T., Garc??a-S??inz, J.A. Mol. Endocrinol. (2006)
- Characterization of the protease activity in the chemotactic factor inactivator. Ward, P.A., Ozols, J. J. Clin. Invest. (1976)
- Mpe1, a zinc knuckle protein, is an essential component of yeast cleavage and polyadenylation factor required for the cleavage and polyadenylation of mRNA. Vo, L.T., Minet, M., Schmitter, J.M., Lacroute, F., Wyers, F. Mol. Cell. Biol. (2001)
- Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a. Robbins, R.A., Hamel, F.G. J. Immunol. (1990)
- Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? Billinger, M., Fleisch, M., Eberli, F.R., Garachemani, A., Meier, B., Seiler, C. J. Am. Coll. Cardiol. (1999)
- Insulin Growth Factor-I and Epidermal Growth Factor Receptors Recruit Distinct Upstream Signaling Molecules to Enhance AKT Activation in Mammary Epithelial Cells. Fleming, J.M., Desury, G., Polanco, T.A., Cohick, W.S. Endocrinology (2006)
- Decreased chemotactic activity in activated newborn plasma. Tannous, R., Spitzer, R.E., Clarke, W.R., Goplerud, C.P., Cavendar-Zylich, N. J. Lab. Clin. Med. (1982)
- Two distinct chemotactic factor inactivators in human serum. Till, G., Ward, P.A. J. Immunol. (1975)
- Relationship between the C5 peptides chemotactic for leukocytes and tumor cells. Romualdez, A.G., Ward, P.A., Torikata, T. J. Immunol. (1976)
- Transcriptional and post-transcriptional regulation of complement factor I (CFI) gene expression in Hep G2 cells by interleukin-6. Minta, J.O., Fung, M., Paramaswara, B. Biochim. Biophys. Acta (1998)
- Alternative pathway complement activation in rheumatoid arthritis. El-Ghobarey, A., Whaley, K. J. Rheumatol. (1980)
- Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid. Vogt, W., Schmidt, G., Lynen, R., Dieminger, L. J. Immunol. (1975)
- Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome. Monteferrante, G., Brioschi, S., Caprioli, J., Pianetti, G., Bettinaglio, P., Bresin, E., Remuzzi, G., Noris, M. Mol. Immunol. (2007)
- Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Fleisch, M., Billinger, M., Eberli, F.R., Garachemani, A.R., Meier, B., Seiler, C. Circulation (1999)
- Alterations in activities of anaphylatoxin inactivator and chemotactic factor inactivator during hemodialysis. McCormick, J.R., Kreutzer, D.L., Keating, H.J., Hupp, J., Despins, A., Moore, M. Am. J. Pathol. (1982)
- A novel oxalosuccinate-forming enzyme involved in the reductive carboxylation of 2-oxoglutarate in Hydrogenobacter thermophilus TK-6. Aoshima, M., Igarashi, Y. Mol. Microbiol. (2006)